Form EFFECT Agomab Therapeutics NV
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:01 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation, Home and Community Based Services Expert Heather Sorrells of Indiana Professional Management Group Outlines Indiana Medicaid Waivers And HCBS Waiver Eligibility Requirements
- Hasbro's Women Innovators of Play Opens Fourth Annual Design Challenge and Expands Program with New In-Person Event Series
- LEAD TECH Turns Booth LU-8931 into a Working Production Line at Pack Expo 2026, Demonstrating CIJ and UV Laser Coding on a Live Conveyor System
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
